Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Cidara’s Rezafungin: US FDA Panel Asked To Weigh ‘Limited Use’ Indication For Antifungal
Jan 20 2023
•
By
Sue Sutter
Rezafungin may be headed for a limited indication. • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers